Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (65) clinical trials

Are you struggling with depressive symptoms? In this clinical trial, patients with depression will be given a standard antidepressant therapy for an 8-week period. At the end of this initial treatment phase, patients will receive an additional medication (either the study drug or placebo). Patients who enter the study and ...

Phase

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

Phase

A Phase III, Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults who have an Inadequate Response to Antidepressant Treatment

Phase

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

Phase

To assess the long-term safety and tolerability of ALKS 5461 for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)

Phase

To evaluate the efficacy of ALKS 5461 for the adjunctive treatment of major depressive disorder (MDD) in adults who have an inadequate response to antidepressant therapy (ADT). To evaluate the safety and tolerability of ALKS 5461 in adults who have MDD and an inadequate response to ADT.

Phase

To evaluate the efficacy, safety and tolerability of Cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD

Phase